1992
DOI: 10.1038/357407a0
|View full text |Cite
|
Sign up to set email alerts
|

Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene

Abstract: Gaucher's disease is the most prevalent lysosomal storage disorder in humans and results from an autosomally inherited deficiency of the enzyme glucocerebrosidase (beta-D-glucosyl-N-acylsphingosine glucohydrolase), which is responsible for degrading the sphingolipid glucocerebroside. An animal model for Gaucher's disease would be important for investigating its phenotypic diversity and pathogenesis and for evaluating therapeutic approaches. A naturally occurring canine model has been reported but not propagate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
172
0
2

Year Published

1993
1993
2008
2008

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 279 publications
(180 citation statements)
references
References 16 publications
5
172
0
2
Order By: Relevance
“…The 12.5-kb genomic fragment contained ϳ4 kb of 5Ј-flanking DNA and extended to the middle of exon 8. The targeting vector was constructed by cloning a 1.8-kb phosphoglycerate kinase (PGK) Neo cassette (43) into the EcoRI/HindIII site of pBluescript SK (Stratagene). The 3Ј end of the targeting construct consisted of a 2-kb mouse P450c17 fragment, generated by digesting the P450c17 genomic clone with AvaI/SstI and blunting the ends with deoxynucleoside triphosphates and DNA polymerase.…”
Section: Methodsmentioning
confidence: 99%
“…The 12.5-kb genomic fragment contained ϳ4 kb of 5Ј-flanking DNA and extended to the middle of exon 8. The targeting vector was constructed by cloning a 1.8-kb phosphoglycerate kinase (PGK) Neo cassette (43) into the EcoRI/HindIII site of pBluescript SK (Stratagene). The 3Ј end of the targeting construct consisted of a 2-kb mouse P450c17 fragment, generated by digesting the P450c17 genomic clone with AvaI/SstI and blunting the ends with deoxynucleoside triphosphates and DNA polymerase.…”
Section: Methodsmentioning
confidence: 99%
“…Genetic defects in several of these hydrolytic enzymes cause various disorders with lysosomal accumulation of the substrate lipids, a group of disorders termed the sphingolipidoses [41,[90][91][92][93]. Particularly, some of the known sphingolipidoses might closely associate with aberrant metabolisms of ceramide because of defective activities of ceramide generating/degrading enzymes: Farber's disease, Gaucher disease, and Niemann-Pick type A and B diseases are caused by a deficiency of acid ceramidase [94,95], glucocerebrosidase (acid-β-glucosidase) [96][97][98], acid SMase [99,100], respectively. The salvage pathway is one of the routes for controlling cellular levels of ceramide.…”
Section: Sphingolipidosesmentioning
confidence: 99%
“…10--15 ES cells from two independent clones, EPl-26 and EP2-173, were microinjected into each blastocoel cavity (26). The blastocysts were then reimplanted into the uterine horn of pseudopregnant CD1 mice.…”
Section: Blastocyst Injection and Animal Breeding Blastocysts Were Omentioning
confidence: 99%